Series E funding round pulls in $54.6M for Natera

05/2/2013 | American City Business Journals

A round of Series E financing has brought in $54.6 million for Natera, maker of the Panorama prenatal DNA test kit used to detect Down syndrome, Patau syndrome and Edwards syndrome. "This new financing will support the expansion of our lab and our team to meet the rapidly increasing demand," said Matthew Rabinowitz, the company's CEO.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health